alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2022341EN.01000301.xml

| 6.9.2022 | EN | Official Journal of the European Union | C 341/3 |
| --- | --- | --- | --- |

6.9.2022

EN

Official Journal of the European Union

C 341/3

---

Prior notification of a concentration

(Case M.10864 - AGC GLASS EUROPE / INTERPANE)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 341/03)

1.

This notification concerns the following undertakings:

| — | AGC Glass Europe SA (‘AGC Glass Europe’, Belgium) |
| --- | --- |

—

AGC Glass Europe SA (‘AGC Glass Europe’, Belgium)

| — | Interpane International Glas GmbH and Interpane Glass Holding AG Interpane (together ‘Interpane’, Germany) |
| --- | --- |

—

Interpane International Glas GmbH and Interpane Glass Holding AG Interpane (together ‘Interpane’, Germany)

AGC Glass Europe will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Interpane.

The concentration is accomplished by way of purchase of shares.

2.

| — | AGC Glass Europe is part of the AGC Group and is ultimately controlled by AGC Inc. AGC Glass Europe produces and processes flat glass for the building industry, the automotive industry, the solar industry and specialist industries through a network of glass production and processing sites across Europe, |
| --- | --- |

—

AGC Glass Europe is part of the AGC Group and is ultimately controlled by AGC Inc. AGC Glass Europe produces and processes flat glass for the building industry, the automotive industry, the solar industry and specialist industries through a network of glass production and processing sites across Europe,

| — | Interpane is a family owned company active in the European architectural glass manufacturing and processing. |
| --- | --- |

—

Interpane is a family owned company active in the European architectural glass manufacturing and processing.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10864 - AGC GLASS EUROPE / INTERPANE

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---
[Federal Register Volume 89, Number 182 (Thursday, September 19, 2024)]
[Notices]
[Pages 76858-76859]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21419]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; RFA-DK25-008: Diabetes 
Research Centers (P30 Clinical Trial Optional).
    Date: November 13-14, 2024.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NIDDK, Democracy II, Suite 
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Lan Tian, Ph.D., Scientific Review Officer, 
National Institute of Diabetes

[[Page 76859]]

and Digestive and Kidney Diseases, National Institutes of Health, 
6707 Democracy Boulevard, Bethesda, MD 20892, (301) 496-7050, 
<a href="/cdn-cgi/l/email-protection#f9959897d78d909897b9979091d79e968f"><span class="__cf_email__" data-cfemail="caa6aba4e4bea3aba48aa4a3a2e4ada5bc">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: September 15, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-21419 Filed 9-18-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2022113EN.01000101.xml

| 9.3.2022 | EN | Official Journal of the European Union | C 113/1 |
| --- | --- | --- | --- |

9.3.2022

EN

Official Journal of the European Union

C 113/1

---

Non-opposition to a notified concentration

(Case M.10514 – DASSAULT SYSTEMES INTERNATIONAL / SZSW / JV)

(Text with EEA relevance)

(2022/C 113/01)

On 1 March 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10514. EUR-Lex is the online point of access to European Union law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10514. EUR-Lex is the online point of access to European Union law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
xml version="1.0" encoding="UTF-8"?


C\_2022388EN.01000701.xml


| | | | |
| --- | --- | --- | --- |
| 10.10.2022 | EN | Official Journal of the European Union | C 388/7 |

---

Prior notification of a concentration

(Case M.10886 – INEOS / SINOPEC / SHANGHAI SECCO PETROCHEMICAL)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 388/07)

1.

On 30 September 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2022388EN.01000701-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | INEOS AG (‘INEOS’, Switzerland), |

| | |
| --- | --- |
| — | China Petroleum and Chemical Corporation (‘SINOPEC’, China), state owned enterprise, |

| | |
| --- | --- |
| — | Shanghai SECCO Petrochemical Co., Ltd. (‘Shanghai SECCO Petrochemical’, China), controlled by SINOPEC. |

INEOS and SINOPEC will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Shanghai SECCO Petrochemical.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are the following:

| | |
| --- | --- |
| — | INEOS is is a privately owned conglomerate that produces a range of chemicals including petrochemicals, specialty chemicals and oil products, |

| | |
| --- | --- |
| — | SINOPEC is a petroleum and petrochemical group headquartered in Beijing, |

| | |
| --- | --- |
| — | Shanghai SECCO Petrochemical is a producer of propylene, polypropylene, acrylonitrile, ethylene, polyethylene, styrene, polystyrene, butadiene and toluene. |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2022388EN.01000701-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10886 – INEOS / SINOPEC / SHANGHAI SECCO PETROCHEMICAL

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| |
| --- |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2022388EN.01000701-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2022388EN.01000701-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 98-20324 Summary Calendar

GERALD T. ARMSTRONG, Petitioner-Appellant,

versus L.W. ZOHN, Sergeant; JOHN DOE; JANE DOE; RONNIE LOPEZ; DENNIS GONDY; LISA JOHNSON; GARY L. JOHNSON, DIRECTOR, TEXAS DEPARTMENT OF CRIMINAL JUSTICE, INSTITUTIONAL DIVISION, Respondents-Appellees.

- - - - - - - - - - Appeal from the United States District Court for the Southern District of Texas USDC No. H-97-CV-2163

- - - - - - - - - - December 7, 1998 Before KING, BARKSDALE, and STEWART, Circuit Judges.
PER CURIAM: * Gerald Thomas Armstrong (#768439), a state prisoner, has requested a certificate of appealability (“COA”) authorizing an appeal from the district court’s order construing his civil rights action as an application for a writ of habeas corpus. The district court dismissed the habeas claims because Armstrong had failed to obtain leave of this court to file a second or successive habeas application. Armstrong v. Johnson , No. H-97- 2163 (S.D. Tex. March 16, 1998) (unpublished). To the extentNo. 98-20324 -2-

** Armstrong has not briefed any issue related the district court’s order dismissing his claim challenging the validity of the parole-revocation proceedings. Accordingly, the claim is abandoned. See Brinkmann v. Dallas County Deputy Sheriff Abner , 813 F.2d 744, 748 (5th Cir. 1987). that Armstrong had raised a civil rights claim, the district court held that the claim must be dismissed under the rule in Heck v. Humphrey , 512 U.S. 477 (1994). Id. Armstrong contends that he was unlawfully arrested prior to the revocation of his supervised release and that he should be permitted to pursue his wrongful-arrest claim under § 1983. ** Applying the reasoning of our opinion in Mackey v. Dickson , 47 F.3d 744, 746 (5th Cir. 1995), we hold that the dismissal of this claim was premature. See also Montoya v. Scott , 65 F.3d 405, 421 (5th Cir. 1995). Because the appeal is from an order dismissing a claim under 42 U.S.C. § 1983, COA is DENIED AS UNNECESSARY. WeVACATE the district court’s judgment dismissing the wrongfularrest claim and REMAND the case for further proceedings.
COA DENIED AS UNNECESSARY; VACATED AND REMANDED.
xml version="1.0" encoding="UTF-8"?


C\_2022329EN.01000501.xml


| | | | |
| --- | --- | --- | --- |
| 31.8.2022 | EN | Official Journal of the European Union | C 329/5 |

---

Prior notification of a concentration

(Case M.10870 - CAPVEST / NATRA)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 329/04)

1.

On 22 August 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2022329EN.01000501-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | CapVest LLP (‘CapVest’, United Kingdom) |

| | |
| --- | --- |
| — | Natra S.A.U. (‘Natra’, Spain) |

CapVest will acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Natra.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are the following:

| | |
| --- | --- |
| — | CapVest is a mid-market private equity firm primarily focused on identifying and managing investments in the healthcare, consumer non-durables, information technology, manufacturing, telecom/media/technology, and life sciences industries, mostly in Europe and North America. CapVest controls the companies Lakeview and Second Nature, two suppliers of desserts and snacks; |

| | |
| --- | --- |
| — | Natra is a company producing and distributing chocolate and cocoa ingredients all over the world. |

4.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2022329EN.01000501-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

5.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10870 – CAPVEST / NATRA

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| |
| --- |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2022329EN.01000501-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2022329EN.01000501-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
# C o u rt o f

A p p ea ls

o f t h e S t a te o f

G eo rg ia

ATLANTA,_

_ _ __ _ _ __ _ __ _ _ _ _ _ __ _
Th e Co u rt

o f Ap p ea l s h er eb y p a s s es t h e f

o ll owi n g o r der :

A1 6 A1 21 7 . J EROME VANALSTYNE v . MONI KE SAPP.

J ero m e Van al s t y

n e fi l ed an ap p li cat i on fo r di re c t a p p eal s eek in g rev i ew o f,
i n t er al i a, t h e t ri al co urt ’ s o rd er d en y i n g h i s m o t i o n to set as i d e a fi n al d i v orce d ecree. Ho wev er, t h e Geo rg i a Su p rem e Co u rt h as ju ri s d ict i o n o ver al l d i v o rce an d al i m o ny

cas es , i n cl u d i n g t h os e cas es an ci l l ary t o t h e d i v o rce p ro ceed i n g s

. See Ga. Co ns t

. 1 9 8 3
, Art

. VI, Sec. VI, Par. III (6 ); M o r r i s v. S u r g es , 2 8 4 Ga. 7 48
, 7 5 0 (2 ) (6 7 0 SE2 d
8 4 ) (2 0 0 8 ); s ee al s o To d

d v. To d d
, 2 8 7 Ga. 2 5 0 (7 0 3 SE2 d 5 9 7 ) (2 0 1 0 ). Becau s e t h e

u n d erl y i n g s ub

ject m at t er o f th i s ap p eal i s d i v orce, it i s hereb y TRANSFERRED t o

t h e Su prem e Co u rt fo r d i s p o s i t i o n

C o u r t o f A p p e a l s o f t h e S t a t e o

f G e o r g ia C le r k ’ s O f f i c e , A t la n t a ,

_

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ I c e r ti f y t h a t t h e a b o v e i s a t r u e e x t r a c t f r o m

t h e m i n u t e s o

f t h e C o u r t o

f A p p e a l s o f G e o r g i a

. W i t n e s s m y s ig n a t u r e a n d t h e s e a l o f s a i d c o u r t
h e r e t o a f f i x e d t h e d a y a n d y e a r l a s t a b o v e w r i t t e n

.

, C l e r k

. 03/28/2016 March 28, 2016
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                       1,096,000
<SECURITIES>                                 2,004,000
<RECEIVABLES>                                3,248,000
<ALLOWANCES>                                   203,000
<INVENTORY>                                  6,319,000
<CURRENT-ASSETS>                            13,484,000
<PP&E>                                       4,570,000
<DEPRECIATION>                               2,228,000
<TOTAL-ASSETS>                              17,899,000
<CURRENT-LIABILITIES>                        6,081,000
<BONDS>                                      3,667,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       909,000
<OTHER-SE>                                   6,378,000
<TOTAL-LIABILITY-AND-EQUITY>                17,899,000
<SALES>                                     17,626,000
<TOTAL-REVENUES>                            17,626,000
<CGS>                                       10,023,000
<TOTAL-COSTS>                               10,023,000
<OTHER-EXPENSES>                             5,596,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             253,000
<INCOME-PRETAX>                              2,038,000
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          2,038,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 2,038,000
<EPS-PRIMARY>                                      .34
<EPS-DILUTED>                                      .30


</TABLE>
<PAGE>   1
 
                                                                   EXHIBIT 23(a)
 
                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
 
     As independent public accountants, we hereby consent to the incorporation
of our report dated February 25, 1997, included herein, into Pennzoil Company's
previously filed Registration Statements on Form S-8 Nos. 2-67268, 2-76935,
2-95869, 33-24261, 33-40192, 33-51473, 33-53783 and 33-63384 and on Form S-3
Nos. 33-50029 and 33-50953.
 
                                          ARTHUR ANDERSEN LLP
 
Houston, Texas
March 4, 1997
Exhibit 32.2  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of China RuiTai International Holdings Co., Ltd. (the Company) on Form 10-KSB for the fiscal year ended December 31, 2007 (the Report), I, Gang Ma, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and 2) The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations.  April 15, 2008 /s/ Gang Ma Chief Financial Officer
United States Court of Appeals

For the Eighth Circuit

___________________________

No. 12-2636

___________________________

Michael J. Conville

lllllllllllllllllllll Appellant

v.

Department of Education, U.S. Secretary Arne Ducan

lllllllllllllllllllll Appellee

____________

 Appeal from United States District Court 

for the Western District of Arkansas - Ft. Smith

____________

 Submitted: February 6, 2013 

Filed: July 12, 2013

[Unpublished]

____________

Before BYE, ARNOLD, and SHEPHERD, Circuit Judges.

____________

PER CURIAM.

Michael Conville filed a complaint for judicial review of an administrative

decision of the Department of Education (DOE) denying discharge of his federally

guaranteed student loans. Both parties moved for summary judgment. Determining

there was no evidence that the DOE’s decision was unreasonable, arbitrary, or
capricious, the district court denied Conville’s motion, granted the DOE’s, and

1

dismissed the complaint. Conville appeals. 

For the reasons the district court stated, we conclude that the DOE was entitled

to summary judgment. See South Dakota v. Dep’t of Interior, 487 F.3d 548, 551 (8th

Cir. 2007) (standard of review). The existence of the student loan debts was

undisputed. Notwithstanding Conville’s arguments,theDOEreasonablydecided that

his debts were enforceable and that there was no basis for their discharge. 

Accordingly, we affirm the judgment of the district court. See 8th Cir. R. 47B.

______________________________

The Honorable Robert T. Dawson, United States District Judge for the

1

Western District of Arkansas.

-2-
### High Production Volume Information System (HPVIS) | High Production Volume (HPV) Challenge | OPPT | US EPA

http://iaspub.epa.gov/hpvis/ServSubmissionPrint [6/15/2011 11:01:18 AM] You are here: EPA Home Prevention, Pesticides & Toxic Substances Pollution Prevention & Toxics High Production Volume (HPV) Challenge High Production Volume Information System (HPVIS) Submission Report 

# High Production Volume Information System (HPVIS)

Contact Us 

### Search: All EPA This Area



# Submission Report

Submission Information

Submission ID : 25419452 Submission Name : 68607283 - Quaternary ammonium compounds, oxydi-2,1- ethanediylbis[coco alkyldimethyl, dichlorides
AR Number :



## Chemical Information

CAS Number : 68607-28-3 Ninth Collective Index Name : Quaternary ammonium compounds, (oxydi-2,1- ethanediyl)bis[coco alkyldimethyl, dichlorides



## Submitter Information

Submitter's Name : Orphan
Address : City : State : VA
ZIP/Postal Code : Country : Type of Submitter : Company 

## Technical Point of Contact Information

Technical Point of Contact : Title : Phone Number : Fax Number : E-Mail Address : 

## Additional Technical Point of Contact Information

Technical Point of Contact : Title : Phone Number : Fax Number : E-Mail Address :


## Sponsor Information Sponsor's Name : Orphan Chemical
Address : City : State : VA
ZIP/Postal Code : Country : US
Phone Number : Share

### High Production Volume Information System (HPVIS) | High Production Volume (HPV) Challenge | OPPT | US EPA

http://iaspub.epa.gov/hpvis/ServSubmissionPrint [6/15/2011 11:01:18 AM] EPA Home Privacy and Security Notice Contact Us http://iaspub.epa.gov/hpvis/ServSubmissionPrint Print As-Is Last updated on Wednesday, June 15, 2011 Fax Number : E-Mail Address : Type of Sponsor : Company 

## Technical Point of Contact Information

Technical Point of Contact : Title : Phone Number : Fax Number : E-Mail Address :